168 related articles for article (PubMed ID: 16595355)
1. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
Stuyt EB; Sajbel TA; Allen MH
Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
3. Alcohol dependence and hospitalization in schizophrenia.
Gerding LB; Labbate LA; Measom MO; Santos AB; Arana GW
Schizophr Res; 1999 Jul; 38(1):71-5. PubMed ID: 10427612
[TBL] [Abstract][Full Text] [Related]
4. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Mohamed S; Rosenheck RA; Lin H; Swartz M; McEvoy J; Stroup S
J Nerv Ment Dis; 2015 Jul; 203(7):486-92. PubMed ID: 26075840
[TBL] [Abstract][Full Text] [Related]
5. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
[TBL] [Abstract][Full Text] [Related]
7. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E
Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
10. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
Akerele E; Levin FR
Am J Addict; 2007; 16(4):260-8. PubMed ID: 17661193
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
[TBL] [Abstract][Full Text] [Related]
13. Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Zedkova I; Dudova I; Urbanek T; Hrdlicka M
Neuro Endocrinol Lett; 2011; 32(5):667-70. PubMed ID: 22167144
[TBL] [Abstract][Full Text] [Related]
14. Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Pathak S; Jiang Y; DiPetrillo L; Todtenkopf MS; Liu Y; Correll CU
J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32220153
[TBL] [Abstract][Full Text] [Related]
15. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
Gianfrancesco F; Rajagopalan K; Goldberg JF; Wang RH
Bipolar Disord; 2007 May; 9(3):252-61. PubMed ID: 17430300
[TBL] [Abstract][Full Text] [Related]
16. Long-term course of substance use disorders among patients with severe mental illness.
Bartels SJ; Drake RE; Wallach MA
Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P
J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
[TBL] [Abstract][Full Text] [Related]
18. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
[TBL] [Abstract][Full Text] [Related]
19. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI
Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758
[TBL] [Abstract][Full Text] [Related]
20. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
Taylor DM; Wright T; Libretto SE;
J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]